Search Results - Perrine Martin
- Showing 1 - 13 results of 13
-
1
-
2
-
3
-
4
-
5
-
6
-
7
1110 Cell depleting agents assessment in preclinical models by Gaëlle Martin, Fabiane Sônego, Yacine Cherifi, Kader Thiam, Angela Pappalardo, Perrine Martin-Jeantet, Alexis Gonon
Published in Journal for ImmunoTherapy of Cancer (2023-11-01)Article -
8
A meta-analysis of the antiviral activity of the HBV-specific immunotherapeutic TG1050 confirms its value over a wide range of HBsAg levels in a persistent HBV pre-clinical model by Roland Kratzer, Benoît Sansas, Karine Lélu, Alexei Evlachev, Doris Schmitt, Nathalie Silvestre, Geneviève Inchauspé, Perrine Martin
Published in Human Vaccines & Immunotherapeutics (2018-06-01)Get full text
Article -
9
Intravenous injection of a novel viral immunotherapy encoding human interleukin-7 in nonhuman primates is safe and increases absolute lymphocyte count by Charles-Antoine Coupet, Clarisse Dubois, Alexeï Evlachev, Nadine Kehrer, Marie Baldazza, Sam Hofman, Michel Vierboom, Perrine Martin, Geneviève Inchauspe
Published in Human Vaccines & Immunotherapeutics (2022-11-01)Get full text
Article -
10
Tumor-dependent myeloid and lymphoid cell recruitment in genO-BRGSF-HIS mice: a novel tool for evaluating immunotherapies by Gaëlle H. Martin, Siham Hedir, Florent Creusat, Alexis Gonon, Amélie Marguier, Perrine Martin-Jeantet, Lise Nouveau, Laura Cons, Florence Renart-Depontieu, Valery Moine, Marc Derive, Yacine Cherifi, Margarida T. Grilo Ruivo, Fabiane Sônego, Kader Thiam
Published in Frontiers in Immunology (2025-09-01)Get full text
Article -
11
Myeloid and dendritic cells enhance therapeutics-induced cytokine release syndrome features in humanized BRGSF-HIS preclinical model by Gaëlle H. Martin, Alexis Gonon, Perrine Martin-Jeantet, Florence Renart-Depontieu, Zuzana Biesova, Anokhi Cifuentes, Arnab Mukherjee, Thomas Thisted, Astrid Doerner, Dean O. Campbell, Ludovic Bourré, Edward H. van der Horst, Amélie Rezza, Kader Thiam
Published in Frontiers in Immunology (2024-02-01)Get full text
Article -
12
Safety and immunogenicity of the therapeutic vaccine TG1050 in chronic hepatitis B patients: a phase 1b placebo-controlled trial by Fabien Zoulim, Claire Fournier, François Habersetzer, Martin Sprinzl, Stanislas Pol, Carla S Coffin, Vincent Leroy, Mang Ma, Heiner Wedemeyer, Ansgar W Lohse, Robert Thimme, Karine Lugardon, Perrine Martin, Bérangère Bastien, Benoit Sansas, Nathalie Adda, Celine Halluard, Kaïdre Bendjama, Maud Brandely, Geneviève Inchauspé
Published in Human Vaccines & Immunotherapeutics (2020-02-01)Get full text
Article -
13
782-D Systemic delivery of novel, allosteric STING agonist CRD3874-SI leads to robust anti-cancer activity by generating pro-inflammatory Type I IFN signals while blocking proton c... by Ciara Kelly, Gaëlle Martin, Fabiane Sônego, Kader Thiam, Angela Pappalardo, Anuj Singh, Monali Banerjee, Sandip Middya, Ritesh Shrivastava, Anindita Middya, Nagaswamy Mane, Nidhi Rawat, Thanilsana Soram, Debjani Chakraborty, Rajib Ghosh, Rubeena Rais Mansuri, Dharmendra Yadav, Anuj Gautam, Kavita Puniya, David Pryde, Sourav Basu, Perrine Martin-Jeantet, Arjun Surya
Published in Journal for ImmunoTherapy of Cancer (2023-11-01)Article
